Applications of R-Ethyl 3-hydroxybutyrate in Industrial Manufacturing

R-Ethyl 3-hydroxybutyrate, produced by our facility with strict batch control, serves as a precise chiral building block in several regulated chemical manufacturing environments. Our in-depth experience as a bulk producer enables integration into high-volume and specialty downstream processes where quality, traceability, and regulatory compliance are essential from raw material logistics to the final product.

1. Pharmaceutical Intermediate for Chiral API Synthesis

API manufacturers use this compound primarily for its high enantiomeric purity and functional group compatibility in asymmetric synthesis routes. Its role as a precursor streamlines the manufacture of cardiovascular, neuroactive, and antidiabetic drug molecules, matching the rising demand for enantiomerically-pure actives. Production pipelines integrate it into key reaction steps—often as a key intermediate in reductions, condensations, or ring-closure transformations—requiring consistent analytical confirmation and impurity profiling, especially when the downstream API targets authorities in regulated markets.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP, Ph. Eur., JP Pharmaceutical Quality Standards (if used in API for corresponding region)
• US FDA DMF requirements (where required)
• EU Directive 2001/83/EC for medicinal products

Typical usage ratio

• 0.5 to 1.2 molar equivalents relative to the key intermediate—ratio tailored to specific synthetic design and final enantiopurity requirements

Downstream process integration

• Charged at enantioselective condensation, hydrogenation, or cyclization stages as chiral precursor
• Introduced after solvent exchange and in-line filtration, with strict in-process QC sampling
• Final intermediate transferred to subsequent isolation and purification under validated conditions

Final product types

• Chiral cardiovascular APIs (e.g., statins, beta-blocker actives)
• Neuroactive agent actives
• Glucose-lowering drug intermediates
• Several finished API substances registered in regulated markets

2. Fine Chemical for Agrochemical Production

Industrial agrochemical manufacturers use R-Ethyl 3-hydroxybutyrate for controlled synthesis of selective herbicides and insecticides, taking advantage of its stereochemistry to introduce bioactivity and reduce off-target effects. Its purity and batch consistency aid in predictable downstream performance and reproducibility in field tests and commercial-scale formulations. Our customers monitor for compliance with hazard communication, environmental controls, and regional notification requirements, especially for products intended for EU or North American regulatory registration dossiers.

Industry compliance standards

• REACH registration (EU)
• EPA 40 CFR Part 158 (US pesticide requirements)
• ISO 9001 for quality management of technical goods
• OECD GLP for studies supporting dossier submissions

Typical usage ratio

• 10–20% by weight in active ingredient synthesis batches—adjusted to target specific chiral centers in the molecule

Downstream process integration

• Dosed at the main cyclization or coupling stage, following solvent charge and base/acid catalyst setup
• Integrated into continuous stirred reactors with in-line monitoring of optical purity and/or final conversion rates
• Intermediate typically isolated before incorporation into bulk technical concentrate

Final product types

• Selective herbicide actives
• Chiral insecticidal intermediates
• Precursor ingredients for crop protection agents
• Technical grade agrochemical APIs supplied to formulation plants

3. Food and Flavor Additive Synthesis

Food ingredient and flavor houses utilize this compound as a precursor for producing high-purity flavors and aroma enhancers, especially in products marketed as “natural-identical” or for fine flavor blending in bakery, dairy, and confectionery sectors. The material enters reactions requiring precise chiral control to meet regional food additive legislation and customer-specific sensory profile requirements. Documented traceability and contaminant controls are prerequisites due to regulatory and GFSI-benchmarked food safety audits.

Industry compliance standards

• EU Regulation (EC) No 1334/2008 on flavorings and certain food ingredients
• 21 CFR Part 172 (Food Additives Permitted for Direct Addition to Food for Human Consumption, US)
• FSSC 22000 food safety certification (where integrated in food manufacturing chain)
• Kosher, Halal, and allergen management as per specific market demands

Typical usage ratio

• 0.05–0.5% by weight in final flavor synthesis, with adjustment for intensity, stability, and compatibility with other formulation ingredients

Downstream process integration

• Added post-extraction or synthesis as a chiral flavor precursor
• Further derivatized or esterified under mild conditions to preserve organoleptic properties
• Blended with supporting ingredients under monitored temperature and vacuum

Final product types

• Baked goods and dairy flavor enhancers
• Fruit and confectionery blends
• Natural-identical flavor ingredients melted into compound flavors
• High-purity aroma compounds for beverages

4. Chiral Building Block for Fine Chemical Research and Synthesis

Chemical research organizations, specialty synthesis houses, and in-house development groups in the electronics and advanced materials industry employ this compound as a starting material for custom synthesis of chiral auxiliaries, monomers, or specialty ligands. Typical processes leverage its defined stereochemistry and reactivity to assemble complex molecules, with process development focused on maximum atom economy and minimization of byproducts. Analytical traceability and documentation support R&D and pilot campaign needs, often with requirements for custom pack sizes and documented change controls.

Industry compliance standards

• ISO 9001 certified production and supply chain
• GLP for laboratory-based research or regulatory test batches
• Customer-specific analytical documentation and purity reporting
• Hazardous chemical registration where required (Globally Harmonized System, regional SDS compliance)

Typical usage ratio

• 0.1–1 molar equivalent depending on process—evaluated during route development and preliminary scale-up campaigns

Downstream process integration

• Used at the initial condensation, alkylation, or ring-closure stage in multi-step syntheses
• Manipulated in glove-box, dry-box, or under inert atmosphere as demanded by highly reactive systems
• Integrated into both solid-phase and solution-phase synthesis lines for library or screening purposes

Final product types

• Custom chiral ligands and auxiliaries for asymmetric catalysis
• Specialty building blocks for materials and pharma R&D
• Advanced intermediates for optically active functional materials
• Research-grade standards for analytical or method development use